HepaTx

HepaTx

HepaTx is a company that develops stem cell-based therapies for liver failure. Their therapies are based on the principles of regenerative medicine, which allow the patient's body to repair damaged tissues and organs. The company's focus is on replacing liver transplants, making it easier for previously untreatable patients to receive cost-effective treatment.

HepaTx's Investors